Gracell also presented data on GC012F for treatment of B-NHL and allogeneic TruUCAR-candidate GC502 for treatment of B-ALL Management to host clinical update call on Monday, June 13, at 8:00AM ET...

Presentation at ENDO 2022 shows similar beneficial improvement in body composition irrespective of metabolic impairment Phase 2b obesity study of bimagrumab monotherapy and co-administration with...

– Epcoritamab shows clinically meaningful efficacy in challenging-to-treat, highly refractory LBCL patients – Total patient population achieved overall response rate (ORR) of 63 percent and...

Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 43rd Annual Healthcare Conference at 1:40 p.m. ET on Wednesday, June 15, 2022. David M. Reese, M.D., executive vice president of Research and...

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in Goldman Sachs' 43rd Annual Global Healthcare...